A 44-year-old male lawyer was found to have a raised serum cholesterol of 8.6 mmol/l and a serum triglyceride of 1.43 mmol/l following an insurance medical. Concurrent optometric examination revealed elevated intraocular pressure (IOP). We describe the subsequent management of this patient and how an oversight of an interesting medical principle can lead to unnecessary treatment with all its sequelae.
Case report
The patient was subsequently referred to an ophthalmology department and a diagnosis of glaucoma was made on the clinical grounds of bilaterally raised IOP of 24 mmhg and the presence of abnormal optic disc appearances. Treatment with topical Timolol 0.5% b.i.d. was commenced.
IOPs remained high and after a year on treatment, topical Pilocarpine 1% t.d.s. was added. This dose was further augmented to Pilocarapine 4% t.d.s. one year later in an attempt to alleviate IOP.
At the same time this patient was attending the Lipid clinic for treatment of his hypercholesterolaemia. Diet treatment and oral Colestifol failed to reduce his levels so Prabistin 10 mg o.d. was prescribed. This caused sleep disturbance. One year later Simvastatin 20 mg o.d. was substituted which lowered the serum cholesterol level to 6.9 mmol/l, but unfortunately this drug induced seborrhoeic dermatitis and was discontinued on the advice of a dermatologist. Several visits to the Lipid clinic with further trials of Clofibrate and Tenofibrate showed little response. The patient's serum cholesterol remained elevated and Fluvastatin 40 mg o.d. was then commenced.
Five years post diagnosis, the patient came under our care. The diagnosis of glaucoma was reconsidered, as visual field testing was normal. The optic discs were not glaucomatous but dysplastic with large cups and normal nerve fibre layer. IOPs were normal in the primary position but became elevated on up gaze. In addition lid lag was present on down gaze.
There was no evidence of lid retraction, soft tissue signs, orbital proptosis or systemic features of thyroid dysfuction. We diagnosed dysthyroid eye disease and discontinued topical treatment. Thyroid function tests were performed and demonstrated a raised thyroid stimulating hormone level of 21.7 mu/l (normal 0.5-5.0), but serum thyroxine was normal. Other routine bloods including full blood count, urea and electrolytes, serum glucose and liver function tests were also normal. Thyroid autoantibodies and TSH receptor assays were not performed. This subclinical hypothyroidism 1 supported our diagnosis of dysthyroid ocular myopathy. Treatment with oral thyroxine was commenced with a subsequent reduction in this patient's serum cholesterol. He remains visually asymptomatic with normal visual fields, unchanged disc appearances, and normal intraocular pressures in the primary gaze position.
Comment
The English, medieval, Franciscan, philosopher William of Occam, proposed the principle of Pluralitas non est ponenda sine necessitate meaning that plurality should not be posited without necessity. Physicians understand this to mean that a patient's diverse symptoms and signs be explained by a single pathophysiology.
Our asymptomatic patient's abnormal lipids and IOP were discovered by separate, ad hoc 'screening' procedures. Initially they were considered separate matters; ultimately a common causation became clearillustrating Occam's razor.
Both elevated lipids 1 and intra-ocular pressure 2 are recognised features of hypothyroidism in Graves disease. Elevated intra-ocular pressure is due to the inelastic inferior rectus muscle compressing the globe as it fails to relax against the upward pull of its antagonist. 3 Failure to recognise underlying hypothyroidism was of practical importance for this patient, who suffered the adverse effects from oral lipid lowering agents, lipid levels only becoming controlled on treatment with Thyroxine. In addition topical Timolol treatment was been shown to cause lipid derangement in healthy volunteers. 4 We feel that hypothyroidism should be considered in patients who present with elevated lipids 1 and elevated IOP-especially when optic discs or visual fields are normal.
Subclinical hypothyroidism may present with a spectrum of clinical ophthalmic signs, but the presence of raised IOP particularly on up gaze, lid lag on down gaze, and the presence of deranged thyroid profiles are sufficient evidence of dysthyroid ocular myopathy in our case. In our opinion the presence of raised intraocular pressure in these patients contraindicates the use of ocular hypotensives in the presence of normal disc appearances and visual fields.
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